In our study, the identified truncating variant in TERF2IP occurred in a patient who also developed primary breast cancer (BUM4), hinting at a possible tumor predisposition syndrome associated with the TERF2IP gene, similar to the one described for the POT1 gene [38]. The gene discussed is POT1; the disease is breast carcinoma.